GRAND ISLAND, N.Y.--(BUSINESS WIRE)--June 1, 2006--Invitrogen Corporation (Nasdaq:IVGN - News), today announced that it has expanded production capabilities of animal-origin free Advanced Granulation Technology (AGT®) media on its Grand Island, New York, campus. Under construction for the past year, a new facility has been validated for production of Invitrogen’s proprietary media formulation in an animal-origin free environment. Several pharmaceutical and biotechnology clients have already begun receiving material manufactured in the facility.
